C
NVO

Certuity’s Novo Nordisk NVO Stock Holding History

Certuity’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,052
Closed -$257K – 689
2025
Q4 		$257K Buy
5,052
+177
+4% +$9.05K 0.02% 470
2025
Q3 		$271K Buy
4,875
+1,230
+34% +$72K 0.02% 427
2025
Q2 		$252K Buy
3,645
+186
+5% +$12.7K 0.02% 338
2025
Q1 		$240K Sell
3,459
-398
-10% -$32.9K 0.03% 326
2024
Q4 		$332K Sell
3,857
-1,343
-26% -$145K 0.04% 244
2024
Q3 		$619K Buy
5,200
+784
+18% +$105K 0.07% 164
2024
Q2 		$630K Buy
4,416
+2,011
+84% +$266K 0.05% 161
2024
Q1 		$317K Buy
2,405
+39
+2% +$4.64K 0.03% 236
2023
Q4 		$257K Buy
+2,366
New +$234K 0.03% 273

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Certuity's NVO Position: Q1 2026 in Review

Certuity sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 5,052 shares — an estimated $257K sold.

Certuity first reported a position in NVO in Q4 2023 and held it in 9 quarters. The position peaked at $630K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Certuity reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Certuity sold 5,052 Novo Nordisk shares in Q1 2026, an estimated $257K.
  • Certuity first reported a position in Novo Nordisk in Q4 2023 and held it in 9 quarters.
  • Certuity's Novo Nordisk position peaked at $630K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Certuity's 13F filing for Q1 2026, filed 11 May 2026.